Market Highlights
The global TMJ disorders market is growing moderately, and it is expected to grow at the same pace over the forecast period 2017-2018. Increasing number of patients affected by TMJ disorder is driving the market growth. Tissue engineering is considered as upcoming trend for treatment of this disorder. Ongoing research on tissue engineering is key driving force for the market growth. In 2015, the company named Renew Health Ltd. got regulatory approval for the use of Cerezen device in UK. This is new and innovative device that can used for the treatment of TMJ disorder.
The global market of TMJ disorders was around USD 940.3 million in 2016 and is expected to reach USD 1229.1 million by 2023 at a projected CAGR of 3.9%.
Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “TMJ disorders market research report–Global forecast to 2023.”
Major Players in TMJ disorders Market
Some of the key market players: AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Jubilant Cadista (US), Pfizer Inc. (US), Sun Pharmaceutical Industries Ltd. (India), and others.
Regional Analysis
The global TMJ disorders market consists of four regions: Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominate this market, particularly North America due to ongoing research and clinical trials. American pharmaceutical companies such as Pfizer Inc. are dominating the global healthcare sector, and these companies are investing a large amount of money for research. Upcoming healthcare bill in the US is expected to lead the market growth in this region. Growing awareness among Latin American population regarding this disorder is another key driver for this market.
Increasing incidence of TMJ disorders drives the European market. Moreover, availability of skilled medical professional and advanced healthcare facilities add fuel to the market growth. This region is mainly divided into Eastern Europe and Western Europe.
Asia Pacific is home to more than half of the world’s population. Increasing healthcare expenditure, government support to improve public health and growing awareness are driving this market. People are getting more aware about this disorder which also playing important role in the growth of the market.
Due to lack of awareness about this disorder and limited access to the healthcare facilities, the Middle East & Africa region is expected to have the least growth during the forecast period
Segmentation
The global TMJ disorders market is segmented on the basis of diagnosis, which includes physical exam, imaging tests, and others. Imaging tests plays important role in diagnosis of this disorder, these tests may include Computerized Tomography (CT) scan, X-rays, Magnetic Resonance Imaging (MRI), TMJ arthroscopy, and others.
On the basis of treatments, the market is segmented into medications, therapies, surgical or other procedures, alternative medicine, and others. Medications is sub-segmented into pain relievers, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others. Some therapies also help to cure this disorder such as Oral splints or mouth guards (occlusal appliances), physical therapy, counseling, and others. Some surgical or other procedures includes arthrocentesis, injections, TMJ arthroscopy, modified condylotomy, open-joint surgery, and others. Alternative medicine is also use for the treatment of this disorder such as acupuncture, relaxation techniques, biofeedback, and others.
On the basis of end user, it is segmented into hospitals & clinics, ambulatory surgery centers, academic institutes, medical research centers, and others.
Access More Report Details @ https://www.marketresearchfuture.com/reports/tmj-disorders-market-4090
No comments:
Post a Comment